TARGETING CD46 FOR BOTH ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER ArticleSu Y., Liu Y., Behrens C.R., Bidlingmaier S., Lee N.K., Liu B., Aggarwal R., Sherbenou D.W., Shuman M.A., Small E.J., Hann B.C., Simko J.P., Premasekharan G., Paris P.L., Burlingame A.L., Seo Y.JCI Insight. Vol. 3. 2018.
EXPRESSION OF P63 IN ADENOCARCINOMA OF THE LUNG AS A FACTOR OF POOR PROGNOSIS. ArticleByakhova M.M., Gurevich L.E., Byakhova V.M.Virchows Archiv-European Journal of Pathology. Vol. 473. 2018. S340 p..